AstraZeneca’s Baxdrostat Shows Strong Phase III Re...
Category : Clinical Trial Update 6 January 2026AstraZeneca has reported encouraging phase III clinical data for baxdrostat, a first-in-class oral a...
AstraZeneca has reported encouraging phase III clinical data for baxdrostat, a first-in-class oral a...
The US Food and Drug Administration has cleared the IND application for GEB-101, enabling the compan...
Nanjing Delova has cleared a major clinical hurdle in postoperative pain management. Two pivotal Pha...
MetaVia has posted eye-catching Phase 1 data for DA-1726, its dual GLP-1/glucagon agonist, showing f...
ScinoPharm Taiwan has achieved a historic milestone. The company has secured US FDA approval for Gla...